X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (167) 167
Publication (29) 29
Conference Proceeding (22) 22
Book / eBook (2) 2
Book Review (2) 2
Patent (2) 2
Web Resource (2) 2
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (94) 94
index medicus (85) 85
hematology (79) 79
oncology (77) 77
male (60) 60
middle aged (59) 59
female (58) 58
adult (55) 55
aged (55) 55
cancer (33) 33
treatment outcome (31) 31
prognosis (29) 29
adolescent (27) 27
antineoplastic combined chemotherapy protocols - therapeutic use (26) 26
remission induction (26) 26
young adult (25) 25
aged, 80 and over (23) 23
leukemia (23) 23
chemotherapy (22) 22
abridged index medicus (21) 21
hematology, oncology and palliative medicine (20) 20
acute myeloid-leukemia (19) 19
acute lymphoblastic leukemia (17) 17
acute lymphocytic leukemia (17) 17
leukemia, myeloid, acute - drug therapy (17) 17
research (17) 17
survival analysis (17) 17
therapy (17) 17
antineoplastic combined chemotherapy protocols - adverse effects (16) 16
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (16) 16
recurrence (16) 16
survival (16) 16
acute lymphoblastic-leukemia (15) 15
aml (15) 15
acute myeloid leukemia (14) 14
minimal residual disease (14) 14
article (13) 13
care and treatment (13) 13
disease-free survival (13) 13
inotuzumab ozogamicin (13) 13
leukemia, myeloid, acute - mortality (13) 13
relapse (13) 13
risk factors (13) 13
transplantation (13) 13
cytarabine - administration & dosage (12) 12
survival rate (12) 12
myelodysplastic syndromes (11) 11
precursor cell lymphoblastic leukemia-lymphoma - therapy (11) 11
retrospective studies (11) 11
acute lymphocytic-leukemia (10) 10
acute myelogenous leukemia (10) 10
adult patients (10) 10
antineoplastic agents - therapeutic use (10) 10
blinatumomab (10) 10
group-b (10) 10
leukemia, myeloid, acute - genetics (10) 10
clinical trials and observations (9) 9
combined modality therapy (9) 9
drug administration schedule (9) 9
hematopoietic stem cell transplantation (9) 9
hematopoietic stem cells (9) 9
precursor cell lymphoblastic leukemia-lymphoma - mortality (9) 9
salvage therapy (9) 9
acute disease (8) 8
acute lymphatic leukemia (8) 8
adults (8) 8
clinical trials as topic (8) 8
diagnosis (8) 8
expression (8) 8
treatment (8) 8
analysis (7) 7
antibodies, monoclonal - therapeutic use (7) 7
antineoplastic combined chemotherapy protocols - administration & dosage (7) 7
calicheamicin (7) 7
cells (7) 7
cytogenetics (7) 7
diseases (7) 7
elderly-patients (7) 7
immunohistochemistry (7) 7
leukemia, myeloid, acute - metabolism (7) 7
leukemia, myeloid, acute - therapy (7) 7
lymphatic leukemia (7) 7
mds (7) 7
mutations (7) 7
oncology, experimental (7) 7
oncology-group (7) 7
patient outcomes (7) 7
precursor cell lymphoblastic leukemia-lymphoma - pathology (7) 7
time factors (7) 7
animals (6) 6
antibodies (6) 6
antibodies, monoclonal - administration & dosage (6) 6
apoptosis (6) 6
clinical trials (6) 6
colony-stimulating factor (6) 6
efficacy (6) 6
gemtuzumab ozogamicin (6) 6
hemic and lymphatic diseases (6) 6
leukemia, myeloid, acute - diagnosis (6) 6
lymphocytic leukemia (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 09/2017, Volume 130, Issue 13, pp. 1487 - 1488
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 08/2019, pp. 1 - 9
Adolescents and young adults (AYAs) with ALL represent a unique population in terms of their biology and treatment. Studies have demonstrated an improved... 
Journal Article
BLOOD, ISSN 0006-4971, 09/2017, Volume 130, Issue 13, pp. 1487 - 1488
In this issue of Blood, Schewe and colleagues identify a novel Fc-engineered CD19 antibody with significant activity in a xenograft model of patient-derived... 
HEMATOLOGY | CD19 | ACUTE LYMPHOBLASTIC-LEUKEMIA | Antibodies | Humans
Journal Article
2010, Contemporary hematology, ISBN 9781607617068
Web Resource
2010, Contemporary hematology, ISBN 9781607617068
Web Resource
New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 21, pp. 2100 - 2101
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2016, Volume 375, Issue 8, pp. 740 - 753
Journal Article
Clinical Lymphoma, Myeloma & Leukemia, ISSN 2152-2650, 2016, Volume 16, pp. S6 - S9
Journal Article
Journal Article
International Journal of Hematologic Oncology, ISSN 2045-1393, 04/2018, Volume 7, Issue 1, p. IJH02
The management of acute lymphoblastic leukemia (ALL) in older patients is challenging. Older patients often have multiple comorbidities and poor performance... 
inotuzumab | blinatumomab | TK inhibitors | acute lymphoblastic leukemia | elderly | Philadelphia chromosome | Studies | Pediatrics | Chemotherapy | Young adults | Comorbidity | Medical prognosis | Older people | Leukemia | Clinical trials | Cytogenetics | Chromosomes | Age
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2019, Volume 25, Issue 3, p. S126
AYA patients have a myriad of specific psychosocial and other challenges which may influence their ability to obtain appropriate treatment. Healthcare... 
Analysis | Stem cells | Bone marrow | Youth | Discrimination in medical care | Teenagers | Health care disparities | Aged | Transplantation | Hematopoietic stem cells
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 21, pp. 2100 - 2101
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 04/2014, Volume 55, Issue 4, pp. 737 - 748
Abstract Chemotherapy alone cures only 25-45% of adult patients with acute lymphoblastic leukemia (ALL), making novel treatment agents and strategies... 
NOTCH1 | Acute lymphoblastic leukemia | alemtuzumab | epratuzumab | chimeric antigen receptor therapy | blinatumomab | decitabine | bortezomib | inotuzumab ozogamicin | rituximab | Chimeric antigen receptor therapy | Epratuzumab | Bortezomib | Blinatumomab | Rituximab | Decitabine | Alemtuzumab | Inotuzumab ozogamicin | ONCOLOGY-GROUP | ACUTE LYMPHOCYTIC-LEUKEMIA | SINGLE-CHAIN ANTIBODY | BITE ANTIBODY BLINATUMOMAB | CELL-ENGAGING ANTIBODY | B-LINEAGE | BRUTONS TYROSINE KINASE | ONCOLOGY | SECRETASE INHIBITOR PF-03084014 | HEMATOLOGY | MINIMAL RESIDUAL DISEASE | fms-Like Tyrosine Kinase 3 - antagonists & inhibitors | Proteasome Inhibitors - pharmacology | Antibodies, Monoclonal - pharmacology | Humans | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Receptors, Antigen, B-Cell - antagonists & inhibitors | Molecular Targeted Therapy | Receptors, Antigen, T-Cell - antagonists & inhibitors | Proteasome Inhibitors - therapeutic use | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Protein Kinase Inhibitors - therapeutic use | Antineoplastic Agents - pharmacology | Protein Kinase Inhibitors - pharmacology | Liposomes | Receptor, Notch1 - antagonists & inhibitors | DNA Methylation - drug effects | Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.